EXU 0.00% 17.0¢ explaurum limited

Ann: Fifth Supplementary Target's Statement, page-2

  1. 2,800 Posts.
    lightbulb Created with Sketch. 590
    retractions , no JORC for MACE and no scoping study.
    surprise!
 
watchlist Created with Sketch. Add EXU (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.